SomnoMed Limited (ASX:SOM)
0.3000
+0.0100 (3.45%)
Oct 27, 2026, 10:53 AM AEDT
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 65.93 million as of October 27, 2026. It is the 30,629th most valuable company in the world and the 702nd biggest in Australia. Its market cap has decreased by 65.66% in one year.
Market Cap
65.93M
Enterprise Value
54.20M
Revenue
114.53M
Global Rank
Country Rank
#702 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 65.93M, an increase of 87.29%. That is a compound annual growth rate of 2.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 65.93M | -60.88% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 114.14M |
| Lumos Diagnostics Holdings | 80.65M |
| Saluda Medical | 65.53M |
| Epiminder | 57.42M |
| Compumedics | 47.94M |
| Cyclopharm | 47.15M |
| Cleo Diagnostics | 43.88M |
| Nova Eye Medical | 42.74M |